Thermo Fisher beats third-quarter estimates on strength in its lab products unit
Thermo Fisher reported Q3 2026 revenue of $12.1B, up about 9% year on year and above consensus. Shares gained in premarket trading on Wednesday.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
According to Seeking Alpha, shares of Thermo Fisher Scientific rose in premarket trading on Wednesday after the life sciences company reported third-quarter 2026 results that came in above expectations. Revenue reached $12.1B, growing about 9% year on year and beating consensus by $190M. Laboratory Products and Biopharma Services led the gains, generating $6.9B with growth of roughly 15%, compared with analysts' forecast of $6.6B.
Life Sciences Solutions and Specialty Diagnostics fell somewhat short. The first brought in $2.7B with growth of about 5%, while the second posted $1.1B, down roughly 7%, against consensus of $2.8B and $1.2B. Adjusted earnings per share came in at $6.68, $0.28 above estimates, and adjusted operating income was about $3.0B with a margin near 25%, versus analysts' projection of about $2.9B. CEO Marc Casper said the company was "very pleased to deliver another excellent quarter" with strong results at both the top and bottom lines. Thermo typically issues its guidance on a conference call at 7:00 a.m. ET.
why it matters
The report shows Thermo Fisher's growth is being carried by lab products and biopharma services, while some other segments lag. For markets, it offers a read on demand for research and diagnostics. The company's guidance on the call will be the next key focus for investors.
market impact
Health care and life science tools: the strong quarter supports interest in TMO and the sector's peers
tags
instruments
sources
- Thermo Fisher posts Q3 beat as lab products unit outperforms — Seeking Alpha, 21 October 2026 at 10:50 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗